Description
Charles G. Thiel Award Sponsored by 3M Drug Delivery Systems In 2010, the Charles G. Thiel award, which recognizes outstanding research and discovery in respiratory drug delivery, was presented to Michael T. Newhouse of Hamilton, Ontario. Mike's contributions to the area as a physician, scientist, inventor and educator have improved the lives of many children and adult patients suffering from lung disease. Mike pioneered the design, manufacture, research into and use of AeroChamber - the device that is now a mainstay of asthma therapy and enables patients to use pressurized metered dose inhalers successfully. Mike was serenaded with 'Ode to AeroChamber'. Ode to AeroChamber Does your inhaler fail to work, ‘cos you inhale too fast? Does your inhaler fail to work, Because of its cold blast? Well AeroChamber can fix that So you can breathe my dear And the guy we have to thank for that Is Michael, who’s right here Mike's many other contributions include the use of gamma scintigraphy to investigate pulmonary ventilation and perfusion; research to enhance our understanding of the origins of occupational and air-pollution related lung disease and the standardization of bronchial provocation tests. Mike spent most of his career as a Clinical Professor of Medicine at McMaster University where he helped found the Firestone Institute for Respiratory Health and the Barnett Medical Aerosol Research Laboratory at St. Joseph's Hospital in Hamilton, Ontario. Mike has been honored as a Fellow of the Royal College of Physicians in Canada and the American College of Physicians. He is a past President of International Society of Aerosols in Medicine (ISAM) and received the ISAM Lifetime Achievement Award in 2005. Mike has made a substantial contribution to our field as a practicing clinician with an outstanding knowledge of pulmonary physiology and an intuitive understanding of aerosol physics - he continuously reminds the aerosol science community to do 'research meaningful to clinical practice'. Congratulations Mike! (Pictured are Charlie Thiel, Mike Newhouse and Lars Borgström together with Stephen Stein from 3M Drug Delivery Systems). Previous Awardees 2008 – Lars Borgström In 2008, the Charles G. Thiel award was presented to Lars Borgström of AstraZeneca. Lars has been at the forefront of correlating and translating in vitro performance of inhaled products to in vivo situations. He has developed and validated charcoal block, isotope labeling and pharmacokinetic techniques for measuring lung deposition, and used these methods to quantify lung deposition in different patient groups. Lars has made a substantial contribution to our understanding of the factors that influence inhaled drug delivery. He has accomplished this at the same time as holding line management responsibilities at AstraZeneca, and an academic position at the University of Uppsala. 2006 - Charles G. Thiel In 2006, the Charles G. Thiel award was presented to Charlie Thiel himself. Charlie has had a long and distinguished career in the industry. He was a joint inventor of the MDI, he designed an early cascade impactor and invented a novel metering valve to improve dosing reproducibility.